Royalty Pharma Plc Stock Probability of Future Stock Price Finishing Over 25.2
| RPRX Stock | USD 25.45 0.22 0.87% |
Royalty |
Royalty Pharma Target Price Odds to finish over 25.2
The tendency of Royalty Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 25.20 in 90 days |
| 25.45 | 90 days | 25.20 | about 91.83 |
Based on a normal probability distribution, the odds of Royalty Pharma to stay above $ 25.20 in 90 days from now is about 91.83 (This Royalty Pharma Plc probability density function shows the probability of Royalty Stock to fall within a particular range of prices over 90 days) . Probability of Royalty Pharma Plc price to stay between $ 25.20 and its current price of $25.45 at the end of the 90-day period is nearly 4.52 .
Given the investment horizon of 90 days Royalty Pharma has a beta of 0.23 indicating as returns on the market go up, Royalty Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Royalty Pharma Plc will be expected to be much smaller as well. Additionally Royalty Pharma Plc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Royalty Pharma Price Density |
| Price |
Predictive Modules for Royalty Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Royalty Pharma Plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Royalty Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Royalty Pharma is not an exception. The market had few large corrections towards the Royalty Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Royalty Pharma Plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Royalty Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | 0.23 | |
σ | Overall volatility | 0.99 | |
Ir | Information ratio | -0.16 |
Royalty Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Royalty Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Royalty Pharma Plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Royalty Pharma Plc generated a negative expected return over the last 90 days | |
| Royalty Pharma Plc has a strong financial position based on the latest SEC filings | |
| About 73.0% of the company shares are owned by institutional investors | |
| On 10th of December 2024 Royalty Pharma paid $ 0.21 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Barclays PLC Raises Stake in Royalty Pharma plc - MarketBeat |
Royalty Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Royalty Stock often depends not only on the future outlook of the current and potential Royalty Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Royalty Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 602.9 M | |
| Cash And Short Term Investments | 495.3 M |
Royalty Pharma Technical Analysis
Royalty Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Royalty Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Royalty Pharma Plc. In general, you should focus on analyzing Royalty Stock price patterns and their correlations with different microeconomic environments and drivers.
Royalty Pharma Predictive Forecast Models
Royalty Pharma's time-series forecasting models is one of many Royalty Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Royalty Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Royalty Pharma Plc
Checking the ongoing alerts about Royalty Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Royalty Pharma Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Royalty Pharma Plc generated a negative expected return over the last 90 days | |
| Royalty Pharma Plc has a strong financial position based on the latest SEC filings | |
| About 73.0% of the company shares are owned by institutional investors | |
| On 10th of December 2024 Royalty Pharma paid $ 0.21 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Barclays PLC Raises Stake in Royalty Pharma plc - MarketBeat |
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.